Uploaded on Apr 16, 2022
MeMed BV is the only test for distinguishing bacterial from viral infections that has been validated in multinational, double-blind and external clinical studies. The clinical studies demonstrating the diagnostic performance of MeMed BV encompassed thousands of patients and are published in high impact medical journals.
Immunoassay Analyzer Test
Immunoassay Analyzer Test
The immunoassay analyzer test is a blood test
that measures the amount of protein in your
blood. Proteins are one of the body's main
building blocks. They include hormones,
antibodies and enzymes.
Have symptoms that suggest a hormone
imbalance or condition associated with a
certain protein, such as Cushing's syndrome or
polycystic ovary syndrome (PCOS)
Know More- Immunoassay Analyzer Test
Are being monitored for response to treatment
for a condition associated with a specific
protein, such as thyroid disorder or cancer
The immunoassay analyzer is a high-tech product
employing the modern biotechnology and
microelectronics technology, which is a new
generation of fully automated blood chemistry
analyzer, using electrochemiluminescence method
to achieve the determination of serum and plasma.
Based on the strong R & D ability and rich practical
experience in medical engineering field for many years,
our company was able to develop this product
independently after three years of hard work. It has
been approved by clinical experts and doctors in many
aspects, such as performance, stability, ease of use and
reliability.
The immunoassay analyzer is mainly used to determine the
amount of free hormone or free drug in serum and
plasma. It can be widely used in biochemical laboratories
in hospitals and scientific research institutes to analyze
hormones, therapeutic drugs, vitamins, tumor markers,
etc.
The term "immunoassay" is a play on words, meaning
assay ("to analyze") using an antigen-antibody reaction.
The use of immunoassays as diagnostic and analytical tools
have become more widespread due to the availability of
monoclonal antibodies, which have made the
development of homogeneous immunoassays possible,
and to the automation of the analytical process.
A sensitive and specific immunoassay for the
detection of estrogen receptor (ER) beta in breast
cancer cell lines and tissue extracts was developed. A
monoclonal antibody, 7B10, was used to detect ER
beta, a novel estrogen-regulated gene expressed in
human breast cancer cells with high affinity for
estradiol (E2).
Using this antibody, ER beta was
specifically detected using
immunoprecipitation and immunoblotting.
Comments